127 related articles for article (PubMed ID: 15851009)
1. Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy.
Lee CH; Wu CL; Tai YS; Shiau AL
Mol Ther; 2005 May; 11(5):707-16. PubMed ID: 15851009
[TBL] [Abstract][Full Text] [Related]
2. Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma.
Lee CH; Wu CL; Shiau AL
Int J Cancer; 2008 Feb; 122(4):930-5. PubMed ID: 17960612
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.
Lee CH; Wu CL; Shiau AL
Cancer Gene Ther; 2005 Feb; 12(2):175-84. PubMed ID: 15375381
[TBL] [Abstract][Full Text] [Related]
4. Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.
Lee CH; Wu CL; Shiau AL
J Gene Med; 2004 Dec; 6(12):1382-93. PubMed ID: 15468191
[TBL] [Abstract][Full Text] [Related]
5. T cell augments the antitumor activity of tumor-targeting Salmonella.
Lee CH; Hsieh JL; Wu CL; Hsu PY; Shiau AL
Appl Microbiol Biotechnol; 2011 May; 90(4):1381-8. PubMed ID: 21360146
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune responses inhibit the antitumor activities mediated by Salmonella enterica serovar choleraesuis.
Lee CH; Wu CL; Chen SH; Shiau AL
J Immunother; 2009 May; 32(4):376-88. PubMed ID: 19342967
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis.
Lee CH; Wu CL; Shiau AL
Clin Cancer Res; 2008 Mar; 14(6):1905-12. PubMed ID: 18347194
[TBL] [Abstract][Full Text] [Related]
8. Tracking of mouse breast cancer stem-like cells with Salmonella.
Chang WW; Kuan YD; Chen MC; Lin ST; Lee CH
Exp Biol Med (Maywood); 2012 Oct; 237(10):1189-96. PubMed ID: 23045719
[TBL] [Abstract][Full Text] [Related]
9. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin.
Goto H; Yano S; Matsumori Y; Ogawa H; Blakey DC; Sone S
Clin Cancer Res; 2004 Nov; 10(22):7671-6. PubMed ID: 15570000
[TBL] [Abstract][Full Text] [Related]
11. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.
Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X
Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188
[TBL] [Abstract][Full Text] [Related]
13. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ
Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984
[TBL] [Abstract][Full Text] [Related]
14. A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.
Vendrell A; Gravisaco MJ; Pasetti MF; Croci M; Colombo L; RodrÃguez C; Mongini C; Waldner CI
Vaccine; 2011 Jan; 29(4):728-36. PubMed ID: 21095252
[TBL] [Abstract][Full Text] [Related]
15. Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities.
Tan GH; Tian L; Wei YQ; Zhao X; Li J; Wu Y; Wen YJ; Yi T; Ding ZY; Kan B; Mao YQ; Deng HX; Li HL; Zou CH; Fu CH
Int J Cancer; 2004 Nov; 112(4):701-6. PubMed ID: 15382054
[TBL] [Abstract][Full Text] [Related]
16. Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin.
Wang R; Zhang XW; Wang GQ; Chen XC; Tian L; Yang HS; Hu M; Peng F; Yang JL; He QM; Zhang W; Jiang Y; Deng HX; Wen YJ; Li J; Zhao X; Wei YQ
Cancer Gene Ther; 2006 Oct; 13(10):940-7. PubMed ID: 16799469
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
[TBL] [Abstract][Full Text] [Related]
18. A polymer coating applied to Salmonella prevents the binding of Salmonella-specific antibodies.
Lee CH; Lin YH; Hsieh JL; Chen MC; Kuo WL
Int J Cancer; 2013 Feb; 132(3):717-25. PubMed ID: 22736433
[TBL] [Abstract][Full Text] [Related]
19. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin.
Yoon AR; Kim JH; Lee YS; Kim H; Yoo JY; Sohn JH; Park BW; Yun CO
Hum Gene Ther; 2006 Apr; 17(4):379-90. PubMed ID: 16610926
[TBL] [Abstract][Full Text] [Related]
20. Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound.
Yu T; Yang Y; Zhang J; He H; Ren X
Eur J Pharm Biopharm; 2015 Apr; 91():103-10. PubMed ID: 25668779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
